We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILPT
3426
Industrial Logistics Properties Trust
ILPT
$595M
$20K ﹤0.01%
6,425
+5,615
+693% +$21.9K
INN
3427
Summit Hotel Properties
INN
$651M
$20K ﹤0.01%
2,822
+412
+17% +$3.13K
LEGH icon
3428
Legacy Housing
LEGH
$698M
$20K ﹤0.01%
890
+45
+5% +$911
LYRA
3429
DELISTED
LYRA THERAPEUTICS INC
LYRA
$20K ﹤0.01%
199
+103
+107% +$12.8K
LZ icon
3430
LegalZoom.com
LZ
$963M
$20K ﹤0.01%
2,145
-4,967
-70% -$42.1K
MYPS icon
3431
PLAYSTUDIOS Inc
MYPS
$63.1M
$20K ﹤0.01%
5,519
-5,450
-50% -$22.1K
NEWP
3432
New Pacific Metals
NEWP
$1.27B
$20K ﹤0.01%
7,100
-1,460
-17% -$3.73K
NEWT icon
3433
NewtekOne
NEWT
$376M
$20K ﹤0.01%
+1,592
New +$26.3K
NHTC icon
3434
Natural Health Trends
NHTC
$15.5M
$20K ﹤0.01%
4,098
+806
+24% +$3.99K
OMER icon
3435
Omeros
OMER
$1.24B
$20K ﹤0.01%
4,461
+446
+11% +$1.61K
PNTG icon
3436
Pennant Group
PNTG
$1.37B
$20K ﹤0.01%
1,453
-1,307
-47% -$16.4K
PRLB icon
3437
Protolabs
PRLB
$2.2B
$20K ﹤0.01%
607
-383
-39% -$11.8K
PTLO icon
3438
Portillo's
PTLO
$374M
$20K ﹤0.01%
948
-3,983
-81% -$83.7K
QCRH icon
3439
QCR Holdings
QCRH
$1.74B
$20K ﹤0.01%
447
-692
-61% -$34.5K
RANI icon
3440
Rani Therapeutics
RANI
$89.5M
$20K ﹤0.01%
3,837
+1,330
+53% +$8K
RCKY icon
3441
Rocky Brands
RCKY
$356M
$20K ﹤0.01%
866
+480
+124% +$13K
RDVT icon
3442
Red Violet
RDVT
$1.12B
$20K ﹤0.01%
1,091
+520
+91% +$11.2K
SBEV icon
3443
Splash Beverage Group
SBEV
$2.55M
$20K ﹤0.01%
75
+18
+32% +$3.57K
SBGI icon
3444
Sinclair Inc
SBGI
$1.07B
$20K ﹤0.01%
1,204
-2,143
-64% -$37.3K
SDIV icon
3445
Global X SuperDividend ETF
SDIV
$1.21B
$20K ﹤0.01%
876
+818
+1,410% +$20.1K
SMBK icon
3446
SmartFinancial
SMBK
$902M
$20K ﹤0.01%
884
+881
+29,367% +$23K
SPHR icon
3447
Sphere Entertainment
SPHR
$6.03B
$20K ﹤0.01%
339
-281
-45% -$15.2K
SRTS icon
3448
Sensus Healthcare
SRTS
$47.1M
$20K ﹤0.01%
3,805
-2,382
-39% -$17.1K
TBPH icon
3449
Theravance Biopharma
TBPH
$881M
$20K ﹤0.01%
1,858
-64
-3% -$677
THR
3450
DELISTED
Thermon Group Holdings
THR
$20K ﹤0.01%
805
+410
+104% +$10K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.